USANA Health Sciences (NYSE:USNA) Stock Rating Lowered by StockNews.com

StockNews.com lowered shares of USANA Health Sciences (NYSE:USNA) from a strong-buy rating to a buy rating in a research note published on Wednesday morning.

Separately, DA Davidson dropped their target price on shares of USANA Health Sciences from $48.00 to $46.00 and set a neutral rating for the company in a report on Tuesday, May 7th.

USANA Health Sciences Trading Up 1.9 %

NYSE USNA opened at $42.62 on Wednesday. The stock has a 50-day moving average of $46.01 and a 200-day moving average of $46.97. USANA Health Sciences has a 1-year low of $40.51 and a 1-year high of $68.00. The firm has a market cap of $811.91 million, a PE ratio of 13.28, a price-to-earnings-growth ratio of 1.41 and a beta of 0.90.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, July 23rd. The company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.11). USANA Health Sciences had a return on equity of 11.13% and a net margin of 6.29%. The firm had revenue of $212.87 million during the quarter, compared to the consensus estimate of $218.64 million. During the same quarter in the prior year, the business posted $0.89 EPS. As a group, equities research analysts forecast that USANA Health Sciences will post 2.48 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Daniel A. Macuga sold 3,791 shares of USANA Health Sciences stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $47.14, for a total value of $178,707.74. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other USANA Health Sciences news, insider Daniel A. Macuga sold 3,791 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $47.14, for a total value of $178,707.74. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Paul A. Jones sold 2,714 shares of USANA Health Sciences stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $48.66, for a total value of $132,063.24. Following the sale, the insider now directly owns 6,266 shares in the company, valued at $304,903.56. The disclosure for this sale can be found here. Insiders sold 31,591 shares of company stock valued at $1,458,098 over the last quarter. 0.33% of the stock is owned by company insiders.

Hedge Funds Weigh In On USANA Health Sciences

A number of institutional investors have recently added to or reduced their stakes in USNA. Vanguard Group Inc. grew its position in shares of USANA Health Sciences by 2.5% in the 3rd quarter. Vanguard Group Inc. now owns 1,567,182 shares of the company’s stock worth $91,853,000 after buying an additional 38,533 shares during the period. Pacer Advisors Inc. grew its holdings in USANA Health Sciences by 75.7% in the fourth quarter. Pacer Advisors Inc. now owns 337,371 shares of the company’s stock worth $18,083,000 after purchasing an additional 145,373 shares during the period. Louisiana State Employees Retirement System bought a new position in shares of USANA Health Sciences during the fourth quarter valued at approximately $300,000. Strs Ohio lifted its holdings in shares of USANA Health Sciences by 9.2% during the fourth quarter. Strs Ohio now owns 11,900 shares of the company’s stock valued at $637,000 after purchasing an additional 1,000 shares during the last quarter. Finally, Cornercap Investment Counsel Inc. purchased a new position in shares of USANA Health Sciences during the fourth quarter valued at approximately $563,000. Institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.